Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Aug;34(8):1051–1056. doi: 10.1136/gut.34.8.1051

Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.

I Sobhani 1, Y Denizot 1, S Hochlaf 1, D Rigaud 1, J Vatier 1, J Benveniste 1, M J Lewin 1, M Mignon 1
PMCID: PMC1374352  PMID: 8174952

Abstract

The release of platelet activating factor (PAF-ACETHER or PAF) and its precursors in the gastric lumen was assessed in 13 normal subjects in basal condition and after stimulation by gastrin. Acid, pepsin, and sialic acid outputs were determined under the same conditions. Gastric juice was collected using a nasogastric tube after overnight fast in basal condition for 60 minutes, then under pentagastrin infusion (6 micrograms/kg/hr for 60 minutes). Platelet activating factor was detected at low concentration in 4/13 subjects under basal condition (mean (SEM) 1.2 (0.6) pg/hr) while high concentrations of lyso platelet activating factor (6.1 (1.8) microgram/hr) and of alkyl-acyl-glycerophosphocholine (AAGPC) (11.5 (3) micrograms/hr) were found in 13 and 11 subjects, respectively. Platelet activating factor was not detected during pentagastrin infusion, while lyso platelet activating factor and alkyl-acyl-glycerophosphocholine were detected in 13 and in 12 subjects, respectively. Compared with the basal condition these platelet activating factor precursors increased significantly (p < 0.001) going up to fivefold baseline (31.8 (6.8) micrograms/hr and 53 (9.3) micrograms/hr respectively) in response to pentagastrin. There was a positive correlation between platelet activating factor precursors and acid or pepsin output but not between platelet activating factor precursors and sialic acid. As sialic acid may be considered an index of mucus glycoprotein degradation, it seems that gastrin stimulation of gastric epithelial cells results in a concomittant secretion of platelet activating factor precursors, acid, and pepsin irrespective of mucus glycoprotein degradation.

Full text

PDF
1051

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benveniste J., Henson P. M., Cochrane C. G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972 Dec 1;136(6):1356–1377. doi: 10.1084/jem.136.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benveniste J., Le Couedic J. P., Polonsky J., Tence M. Structural analysis of purified platelet-activating factor by lipases. Nature. 1977 Sep 8;269(5624):170–171. doi: 10.1038/269170a0. [DOI] [PubMed] [Google Scholar]
  4. Camussi G., Aglietta M., Malavasi F., Tetta C., Piacibello W., Sanavio F., Bussolino F. The release of platelet-activating factor from human endothelial cells in culture. J Immunol. 1983 Nov;131(5):2397–2403. [PubMed] [Google Scholar]
  5. Cazenave J. P., Benveniste J., Mustard J. F. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest. 1979 Sep;41(3):275–285. [PubMed] [Google Scholar]
  6. Cucala M., Wallace J. L., Salas A., Guarner F., Rodriguez R., Malagelada J. R. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats. Prostaglandins. 1989 Feb;37(2):275–285. doi: 10.1016/0090-6980(89)90063-4. [DOI] [PubMed] [Google Scholar]
  7. Denizot Y., Sobhani I., Rambaud J. C., Lewin M., Thomas Y., Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut. 1990 Nov;31(11):1242–1245. doi: 10.1136/gut.31.11.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eliakim R., Karmeli F., Razin E., Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology. 1988 Nov;95(5):1167–1172. doi: 10.1016/0016-5085(88)90346-0. [DOI] [PubMed] [Google Scholar]
  9. Esplugues J. V., Whittle B. J. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. Am J Physiol. 1989 Feb;256(2 Pt 1):G275–G282. doi: 10.1152/ajpgi.1989.256.2.G275. [DOI] [PubMed] [Google Scholar]
  10. Foa R., Bussolino F., Ferrando M. L., Guarini A., Tetta C., Mazzone R., Gugliotta L., Camussi G. Release of platelet-activating factor in human leukemia. Cancer Res. 1985 Sep;45(9):4483–4485. [PubMed] [Google Scholar]
  11. Harper M. J. Platelet-activating factor: a paracrine factor in preimplantation stages of reproduction? Biol Reprod. 1989 May;40(5):907–913. doi: 10.1095/biolreprod40.5.907. [DOI] [PubMed] [Google Scholar]
  12. Johnson A. G., McDermott S. J. Lysolecithin: a factor in the pathogenesis of gastric ulceration? Gut. 1974 Sep;15(9):710–713. doi: 10.1136/gut.15.9.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jouvin-Marche E., Ninio E., Beaurain G., Tence M., Niaudet P., Benveniste J. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. J Immunol. 1984 Aug;133(2):892–898. [PubMed] [Google Scholar]
  14. Kald B., Olaison G., Sjödahl R., Tagesson C. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa. Digestion. 1990;46(4):199–204. doi: 10.1159/000200346. [DOI] [PubMed] [Google Scholar]
  15. Kawasaki T., Snyder F. The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. Biochim Biophys Acta. 1987 Jul 13;920(1):85–93. doi: 10.1016/0005-2760(87)90314-6. [DOI] [PubMed] [Google Scholar]
  16. Korth R., Benveniste J. BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. Eur J Pharmacol. 1987 Oct 27;142(3):331–341. doi: 10.1016/0014-2999(87)90071-9. [DOI] [PubMed] [Google Scholar]
  17. Lee T., Lenihan D. J., Malone B., Roddy L. L., Wasserman S. I. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem. 1984 May 10;259(9):5526–5530. [PubMed] [Google Scholar]
  18. McIntyre T. M., Zimmerman G. A., Satoh K., Prescott S. M. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest. 1985 Jul;76(1):271–280. doi: 10.1172/JCI111957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mencia-Huerta J. M., Lewis R. A., Razin E., Austen K. F. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J Immunol. 1983 Dec;131(6):2958–2964. [PubMed] [Google Scholar]
  20. Nogami M., Suko M., Miyamoto T. The effect of platelet-activating factor on [14C]aminopyrine uptake by isolated guinea pig parietal cells. Biochem Biophys Res Commun. 1990 May 16;168(3):1047–1052. doi: 10.1016/0006-291x(90)91135-f. [DOI] [PubMed] [Google Scholar]
  21. Prescott S. M., Zimmerman G. A., McIntyre T. M. Platelet-activating factor. J Biol Chem. 1990 Oct 15;265(29):17381–17384. [PubMed] [Google Scholar]
  22. Rosam A. C., Wallace J. L., Whittle B. J. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986 Jan 2;319(6048):54–56. doi: 10.1038/319054a0. [DOI] [PubMed] [Google Scholar]
  23. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990 Nov;259(5 Pt 1):C697–C708. doi: 10.1152/ajpcell.1990.259.5.C697. [DOI] [PubMed] [Google Scholar]
  24. Sobhani I., Denizot Y., Vissuzaine C., Vatier J., Benveniste J., Lewin M. J., Mignon M. Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man. Dig Dis Sci. 1992 Oct;37(10):1583–1592. doi: 10.1007/BF01296506. [DOI] [PubMed] [Google Scholar]
  25. Sobhani I., Hochlaf S., Denizot Y., Vissuzaine C., Rene E., Benveniste J., Lewin M. M., Mignon M. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut. 1992 Sep;33(9):1220–1225. doi: 10.1136/gut.33.9.1220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tencé V., Polonsky J., Le Couedic J. P., Benveniste M. J. Release, purification, and characterization of platelet-activating factor (PAF). Biochimie. 1980;62(4):251–259. doi: 10.1016/s0300-9084(80)80399-3. [DOI] [PubMed] [Google Scholar]
  27. Touqui L., Shaw A. M., Dumarey C., Jacquemin C., Vargaftig B. B. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. Biochem J. 1987 Jan 15;241(2):555–560. doi: 10.1042/bj2410555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vatier J., Poitevin C., Mignon M. Sialic acid content and proteolytic activity in gastric juice in humans. An approach for appreciating mucus glycoprotein erosion. Dig Dis Sci. 1988 Feb;33(2):144–151. doi: 10.1007/BF01535724. [DOI] [PubMed] [Google Scholar]
  29. Vatier J., Poitevin C., Vitré M. T., Mignon M. Caractérisation et évaluation du caractère pathogène du reflux duodénogastrique par la mesure de la choline et de l'acide sialique intragastriques chez le sujet normal et l'ulcéreux duodénal. Gastroenterol Clin Biol. 1988 Mar;12(3):207–213. [PubMed] [Google Scholar]
  30. Vatier J., Sauvage M., Lewin M., Bonfils S. Approche d'une détermination automatique de l'activité protéolytique du suc gastrique dans les conditions de vitesse initiale de la réaction. Biol Gastroenterol (Paris) 1975 Apr-May;8(2):107–115. [PubMed] [Google Scholar]
  31. Wallace J. L., Keenan C. M. Leukotriene B4 potentiates colonic ulceration in the rat. Dig Dis Sci. 1990 May;35(5):622–629. doi: 10.1007/BF01540411. [DOI] [PubMed] [Google Scholar]
  32. Wallace J. L. Lipid mediators of inflammation in gastric ulcer. Am J Physiol. 1990 Jan;258(1 Pt 1):G1–11. doi: 10.1152/ajpgi.1990.258.1.G1. [DOI] [PubMed] [Google Scholar]
  33. Wykle R. L., Malone B., Snyder F. Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. J Biol Chem. 1980 Nov 10;255(21):10256–10260. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES